American drugmaker Pfizer is close to a deal to purchase Global Blood Therapeutics, which manufactures a recently approved drug against sickle-cell anemia, for $5 billion, the Wall Street Journal has. . . ....


Comments
  • No comment posted so far for this feed.
    Be the first one to post.
Please login to post comment!